GOSSELIES, BELGIUM

The Clinical Cell Therapy manufacturing facility in Gosselies, Belgium is 25,830 sq. ft. and offers autologous and allogeneic clinical cell therapy manufacturing. The facility accommodates 4 process development labs, 10 agility by design clean rooms for EU and US CGMP manufacturing, grade B storage, nitrogen storage, fill/finish services, and quality control labs.

An additional large-scale commercial dedicated plant is currently under construction and expected to be fully commissioned in 2021. The space is 61,355 sq. ft. and will contain autologous and allogeneic dedicated platforms, FDA/EU fitted, and a large-scale fill/finish area.

Size: 25,000+ ft²

CELL THERAPY CAPABILITIES

• Process Development/Industrialization
• EU and US CGMP Clinical and Commercial Manufacturing
• Analytical Services
• Fill/Finish

FEATURED TECHNOLOGIES

• Chimeric Antigen Receptor (CAR)-T
• T Cell Receptors (TCR) and Tumor Infiltrating Lymphocytes (TIL)
• Mesenchymal Stem Cells (MSCs)
• Natural Killer Cells (NKs)

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume, or contact us at careers@catalent.com.